Feed / KYMR

Kymera Therapeutics, Inc.

KYMR

Healthcare · 120.04 -1.2% today

Isolated · not yet confirmedMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

Kymera Therapeutics, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 37 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.

Company-1.2% todayVolume comparison unavailable
Market group0 of 37 activeBiotechnology · unavailable
Disclosed network0 of 7 confirmingNo filing-linked name is confirming now
What would change this read
  • R&D rose to $119.5 million, including a $36.1 million increase tied to the STAT6 program and higher internal investment.

Invalidation: The isolated read changes if KYMR's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind KYMR

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

GILDGilead Sciences, Inc.partnerApr 30, 2026 ▾

“In June 2025, we announced a strategic collaboration with Gilead Sciences, Inc.”

SNYSanofipartnerFeb 26, 2026 ▾

“We are collaborating with Sanofi S.A.”

Depended on by

GILDGilead Sciences, Inc.partnerFeb 24, 2026 ▾

“Entered into an exclusive option and license agreement with Kymera Therapeutics, Inc.”

Filing peers

CRVSCLDXSYRE

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 7 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

KYMR is currently a Follower in the organic co-movement group Biotechnology. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.